Evidence map›Paper›PMID 30782218›Full record

ArticleSystematic reviews2019

Association of incident dialysis modality with mortality: a protocol for systematic review and meta-analysis of randomized controlled trials and cohort studies.

Mark R Marshall, Chun-Yuan Hsiao, Philip K Li, Masaaki Nakayama, S Rabindranath, Rachael C Walker, Xueqing Yu, Suetonia C Palmer

Abstract read
In one paragraph

Article in Systematic reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mark R MarshallSchool of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Mark.Marshall@middlemore.co.nz.ORCID 0000-0003-0499-4527
Chun-Yuan HsiaoDepartment of Renal Medicine, Middlemore Hospital, Counties Manukau Health, Auckland, New Zealand.
Philip K LiDepartment of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Masaaki NakayamaResearch Division of Chronic Kidney Disease and Dialysis Treatment, Tohoku University Hospital, Sendai, Japan.
S RabindranathDepartment of Nephrology, Waikato District Hospital, Hamilton, New Zealand.
Rachael C WalkerNursing and Health Science, Eastern Institute of Technology, Hawke's Bay, New Zealand.
Xueqing YuInstitute of Nephrology, Guangdong Medical University, Dongguan, Guangdong, China.
Suetonia C PalmerDepartment of Medicine, University of Otago Christchurch, Christchurch, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt least 2.6 million adults and children receive dialysis treatment for end-stage kidney disease (ESKD) worldwide. The large majority of these receive hemodialysis (HD), while the remaining receive peritoneal dialysis (PD). Peritoneal dialysis may be associated with similar mortality outcomes as HD, and patient-reported outcomes are potentially increased with PD. Existing evidence for the mortality associated with PD was summarized over 20 years ago, and there has been greater marginal improvement in survival with PD relative to HD since that time. It is therefore timely to reexamine the question of differential mortality by modality and summarize evidence from more contemporary practice settings. METHODS/

designElectronic databases will be systematically searched for publications that report the association between dialysis modality (HD or PD) with death from any cause and cause-specific death in incident patients with end-stage kidney disease. The database searches will be supplemented by searching through citations and references and consultation with experts. Studies published before 1995 will be excluded. Screening of both titles and abstracts will be done by two independent reviewers. All disagreements will be resolved by an independent third reviewer. A quantitative meta-analysis of effect sizes and standard errors will be applied. DISCUSSION: Our systematic review will update previous evidence summaries and provide a quantitative and standardized assessment of the contemporary literature comparing HD and PD including published and unpublished non-English studies from greater China, Taiwan, and Japan. This review will inform shared decision-making around initial dialysis modality choice and jurisdiction-level considerations of dialysis practice. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018111829.

Indexed as

Cause of DeathCohort StudiesHumansKidney Failure, ChronicMeta-Analysis as TopicPeritoneal DialysisRandomized Controlled Trials as TopicRenal DialysisResearch DesignSurvival RateSystematic Reviews as TopicCause-specific mortalityHemodialysisMortalityPeritoneal dialysisSystematic review

Identifiers

PMID30782218
PMCPMC6379951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.